- October 17, 2017 at 08:12 #3817
For many connective tissue disorders, a multidisciplinary method of treatment is essential. The incorporation of maternal-fetal medicine subspecialists, rheumatologists, cardiologists, along with other necessary specialists will offer the patient the best chance for early recognition and control over disease progression or of pregnancy compromise.
Although nearly all pregnancies when women have connective tissue disorders can lead to normal outcomes, understanding of the initial challenges of these disorders that may present during the pregnancy is vital to be able to recognize and address fetal and maternal impact within the pre-conceptual, antepartum and postpartum states.
Initiation or modification of medicines is suitable to acquire therapeutic effect using the cheapest possible dose along with the safest medication. Close patient follow-up throughout the immediate postpartum period is important with mindfulness targeted at potential disease exacerbation or return in addition to elevated risks for growth and development of co-morbidities.
You must be logged in to reply to this topic.